Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thrombophilia × Injections × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Thrombosis 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Disease 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombophilia 1 Thrombocytopenia 1 Thoracic Neoplasms 1 Skin Neoplasms 1 Pituitary Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Papillomavirus Infections 1

Interventions

enoxaparin sodium 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡